2012.,Cancer Facts and Figures 2012. Atlanta: American Cancer Society -
JemalA,BrayF,CenterMM,FerlayJ,WardE,FormanD, 2011.,CA Cancer J Clin 61 69 -90
BellDW, 2010.Our changing view of the genomic landscape of cancer,J Pathol 220 231 -43
WoodLD,ParsonsDW,JonesS,LinJ,SjöblomT,LearyRJ, 2007.The genomic landscapes of human breast and colorectal cancers,Science 318 1108 -13
SajidMT,AhmedM,AzharM,MustafaQU,ShukrI,AhmedM, 2014.Age-related frequency of triple negative breast cancer in women,J Coll Physicians Surg Pak 24 400 -3
HirshfieldKM,RebbeckTR,LevineAJ, 2010.Germline mutations and polymorphisms in the origins of cancers in women,J Oncol 297671 -
GiacomazziJ,SelistreSG,RossiC,AlemarB,Santos-SilvaP,PereiraFS, 2013.Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil,Cancer 119 4341 -9
McGowanEM,LinY,Hatoum D, 2018.Good guy or bad guy? The duality of wild-Type p53 in hormone-dependent breast cancer origin, treatment, and recurrence,Cancers E172 -
FinettiP,GuilleA,AdelaideJ,BirnbaumD,ChaffanetM,BertucciF., 2014.ESPL1 is a candidate oncogene of luminal B breast cancers,Breast Cancer Res Treat 147 51 -9
2012.Comprehensive molecular portraits of human breast tumours,Nature 490 61 -70
SaeedM,MahmoudN,SugimotoY,EfferthT,Abdel-Aziz H, 2018.Molecular determinants of sensitivity or resistance of cancer cells toward sanguinarine,Front Pharmacol 9 136 -
BrewerHR,JonesME,SchoemakerMJ,AshworthA,SwerdlowAJ, 2017.Family history and risk of breast cancer: an analysis accounting for family structure,Breast Cancer Res Treat 165 193 -200
Livaudais-TomanJ,KarlinerLS,TiceJA,KerlikowskeK,GregorichS,Pérez-StableEJ, 2015.Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial,Breast 24 758 -66
SeneviratneS,CampbellI,ScottN,ShirleyR,LawrensonR, 2015.Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: A cohort study,BMC Public Health 15 46 -
MudvariP,OhshiroK,NairV,HorvathA,KumarR, 2013.Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems,PLoS One 8 e74993 -
Darb-EsfahaniS,DenkertC,StenzingerA,SalatC,SinnB,SchemC, 2016.Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy,Oncotarget 7 67686 -98
QinJJ,WangW,ZhangR., 2017.Experimental therapy of advanced breast cancer: Targeting NFAT1-MDM2-p53 pathway,Prog Mol Biol Transl Sci 151 195 -216
YuanY,KosFJ,HeTF,YinHH,LiM,HardwickN, 2017.Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab,Oncoimmunology 6 e1363138 -
SynnottNC,BauerMR,MaddenS,MurrayA,KlingerR,O'Donovan N, 2018.Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007,Cancer Lett 414 99 -106
AhnKJ,ParkJ,ChoiY., 2017.Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery,Radiat Oncol J 35 332 -9
SaunusJM,SmartCE,KutasovicJR,JohnstonRL,Kalita-de CroftP,MirandaM, 2018.Multidimensional phenotyping of breast cancer cell lines to guide preclinical research,Breast Cancer Res Treat 167 289 -301
JinJ,ZhangW,JiW,YangF,GuanX, 2017.Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy,Cancer Biol Ther 18 369 -78
Lolas HamamehS,RenbaumP,KamalL,DweikD,SalahatM,JaraysaT, 2017.Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53,Int J Cancer 141 750 -6
BaloghGA,MailoD,NardiH,CorteMM,VincentE,BaruttaE, 2010.Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients,Exp Ther Med 1 357 -61
SadighiS,ZokaasadiM,KasaeianA,MaghsudiS,JahanzadI, 2017.The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome,PLoS One 12 e0182444 -